Amphastar Pharmaceuticals, Inc. (AMPH)
26.07
+0.07
(+0.27%)
USD |
NASDAQ |
Jan 16, 16:00
26.07
0.00 (0.00%)
After-Hours: 16:02
Amphastar Pharmaceuticals SG&A Expense (TTM): 126.42M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Supernus Pharmaceuticals, Inc. | 442.58M |
| Catalyst Pharmaceuticals, Inc. | 162.44M |
| Pfizer Inc. | 13.91B |
| CorMedix, Inc. | 75.56M |